Table 1.

Clinical parameters and outcome of patient who underwent neoadjuvant chemotherapy prior to surgery versus surgery alone

Patient no.	TMN staging	Neoadjuvant therapy	Tumor pathology	SA-β-gal		Follow-up
Patient no.	TMN staging	Neoadjuvant therapy	Tumor pathology	Lung	Tumor	Follow-up
1	T₂N₀M₀	Carboplatin/taxol × 3	Complete response	+/−	NA	No evidence of disease/18 mo
2	T₃N₁M₀	Carboplatin/taxol × 3	Viable tumor	+/−	++++	Deceased/recurrent disease/14 mo
3	T₃N₀M₀	Carboplatin/taxol × 3	Viable tumor	+/−	+++	No evidence of disease/11 mo
4	T₃N₀M₀	None	Viable tumor	−	−	No evidence of disease/16 mo
5	T₂N₀M₀	None	Viable tumor	+/−	+/−	No evidence of disease/13 mo
6	T₂N₀M₀	None	Viable tumor	−	−	No evidence of disease/11 mo